Yahoo! News - Parents: Kids Face Antidepressants Risk
Search the web
Yahoo! NewsSign In
New User? Sign Up
Welcome, Guest Personalize News Home Page   -   Sign In
Yahoo! News   Mon, Feb 02, 2004
Search   for     Advanced
News Home
Top Stories
U.S. National
   Weight Loss
   Sexual Health
Most Popular
Oddly Enough
News Photos
Most Popular
Full Coverage

Full Coverage
More about
Mental Health
Related News Stories
FDA Panel to Weigh Safety Of Mood Drugs for Children at Washington Post (Feb 2, 2004)
Teen girls more prone to depression, study says at Globe and Mail. (Feb 2, 2004)
Moms' Blues Bad News for Their Kids HealthDay via Yahoo! News (Feb 2, 2004)
Opinion & Editorials
Who will take on pharmaceutical companies? at San Jose Mercury News (Feb 2, 2004)
Official indifference to mental health crisis at The Virginian-Pilot (Feb 1, 2004)
Feature Articles
Will British Ban Spur FDA to Act? at Insight on the News (Feb 2, 2004)
Prescription For Suicide? at TIME Magazine (Feb 1, 2004)
Related Web Sites
Mental Health: A Report of the Surgeon General
Center for Mental Health Services - Knowledge Exchange Network
Depression Screening

News Resources
· Reuters
· AP
· HealthDay
· ACS News Today
· CP
News Alerts
· Food and Drug Administration
·Daily Emails
·Free News Alerts
 News via RSS

Health - AP
Parents: Kids Face Antidepressants Risk
28 minutes ago
Add Health - AP to My Yahoo!


WASHINGTON - Parents need warnings that popular adult antidepressants may sometimes spur suicide when taken by children and teenagers, government advisers said Monday after hearing emotional testimony from families who lost loved ones.

AP Photo

In Yahoo! Health
Chronic Heartburn Chronic Heartburn
Need Relief?

More from Yahoo! Health:
Check Your Symptoms
How Is It Diagnosed?
Available Treatments

It isn't clear yet that the drugs lead to suicide, but until that is settled, parents and doctors need to know they may cause agitation, anxiety and hostility in a subset of young patients who may be unusually prone to rare side effects, advisers to the Food and Drug Administration (news - web sites) concluded.

"We want to put a speed bump in the road," said panel chair Dr. Matthew Rudorfer of the National Institute of Mental Health. "The warnings as they exist in the current labeling are not adequate or are not being taken seriously."

British health authorities sounded the alarm last year, saying long-suppressed research suggests certain antidepressants might sometimes increase the risk of suicidal behavior in children and teenagers. Because only one drug, Prozac, has been proven to alleviate pediatric depression, Britain declared others — drugs called SSRIs and their close relatives — unsuitable for depressed youth.

Now, the FDA is wrestling with whether the suicide risk is real, and if so, what to do here. It's difficult, because depression itself can cause suicide.

Among 25 studies of the suspect medications involving 4,000 children and teens, there were no completed suicides. But 109 patients experienced one or more possibly suicide-related behaviors or attempts, FDA medical reviewer Dr. Thomas Laughren revealed Monday.

The problem, he said, is that studies varied dramatically in what was considered suicidal behavior. Among 19 patients classified as cutting themselves, for instance, almost all were superficial, with little bleeding. So FDA has hired Columbia University to help determine exactly how much true suicidal behavior occurred, before it proposes next steps at a second public hearing in late summer.

Meanwhile, FDA has warned doctors to use great caution in prescribing any antidepressant other than Prozac to people under 18.

That's not enough, said anguished parents who want warnings of the possible suicide risk on the drugs' labels.

"You have an obligation today ... from preventing this tragic story from being repeated over and over again," said Mark Miller of Kansas City, Mo., whose 13-year-old son Matt hanged himself in his bedroom closet after taking his seventh Zoloft pill.

"Please, save our children," said Todd Shivak of Michigan, whose 11-year-old son Michael slashed his wrists in class, but survived, while taking Paxil.

Parents described youths becoming extremely agitated or anxious shortly after starting the pills — symptoms known medically as akathisia — and seemingly sudden impulses that turned deadly.

FDA's scientific advisers warned that the youths most likely to commit suicide weren't allowed into the SSRI studies, so existing data likely won't settle the issue.

But the panel urged FDA to heed parents' reports about akathisia — and to run some sort of education campaign about those symptoms, so young patients can be better monitored.

"Perhaps just looking at suicide attempts may not be all the answer," said Dr. Joan Chesney, a University of Tennessee pediatrician.

"I doubt that pediatricians or family practitioners are aware of the level of concern about this potential problem," said Dr. Norman Fost, a University of Wisconsin pediatrician and bioethicist. Until FDA settles the issue, "you should be very alert to the risks of these drugs, be very alert to this ... syndrome."

Some families also blamed murder and school violence on the drugs.


"These drugs are hell, look what they've done to my son," say Jay Baadsgaard after his son Corey described taking Effexor and then waking up in jail, claiming no memory of holding his Mattawa, Wash., class hostage at gunpoint four years ago.

But a few parents, despite boos from the crowd, credited the drugs with saving their children.

"I ask that you appreciate the enormous benefit these medicines have had," said Sherri Walton of Arizona, whose 14-year-old daughter Jordan has used SSRIs in a years-long battle with obsessive-compulsive disorder and depression. "Her medicines were sometimes the only things she could depend on to help her."

"I shudder to think of their plight if these medicines were not available," added Suzanne Vogel-Scibilia of the patient group National Alliance for the Mentally Ill, who say the drugs dramatically improved depression in two of her teen sons, including one who had attempted suicide.

FDA officials fear warnings before the issue is settled could dissuade patients from potentially helpful treatment. "To err in either direction has significant consequences," said Laughren.

Depression occurs in up to 10 percent of youth, and 1,883 10- to 19-year-olds killed themselves in 2001. Some 1.8 million teenagers attempted suicide that year, a quarter of them requiring medical attention, said Dr. David Schaffer of Columbia University.

In 2002, almost 11 million prescriptions were dispensed to patients under 18 for SSRIs and other newer antidepressants, to treat depression and a host of other conditions, FDA said.

Mail to Friend  Email Story
Message Boards   Post/Read Msgs (372)
Printer Version   Print Story
Ratings: Would you recommend this story?
Not at all 1 - 2 - 3 - 4 - 5 Highly

Special Feature

Store Anything
You can't afford to scrimp--get the hard facts on hard drives

Next Story: Pizza Makers Consider Low-Carb Dough  (AP)

More Health Stories
· Detect Vision Problems Early  (HealthDay)
· Is Salmon Safe?  (American Cancer Society)
· Bird flu claims two more lives amid fears human flu virus has hit Asia  (AFP)
· U.S. Advisers Seek Stronger Antidepressant Warning  (Reuters)
· Pizza Makers Consider Low-Carb Dough   (AP)

Online Graduate Degrees in Health
Online Graduate Degrees in Health
Browse All Health Programs
from Yahoo! Education

Copyright (c) 2004 The Associated Press. All rights reserved. The information contained in the AP News report may not be published, broadcast, rewritten or redistributed without the prior written authority of The Associated Press.
Copyright © 2004 Yahoo! Inc. All rights reserved.
Questions or Comments
Privacy Policy -Terms of Service - Copyright Policy - Ad Feedback